Trial · NCT00414973

Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected
Total, all-cause mortality	Teriparatide - Females
Total, all-cause mortality	Calcitonin - Females
Total, all-cause mortality	Teriparatide - Males
Total, all-cause mortality	Calcitonin - Males
Total, other adverse events	Teriparatide - Females	67
Total, other adverse events	Calcitonin - Females	26
Total, other adverse events	Teriparatide - Males	7
Total, other adverse events	Calcitonin - Males	0
Total, serious adverse events	Teriparatide - Females	8
Total, serious adverse events	Calcitonin - Females	1
Total, serious adverse events	Teriparatide - Males	2
Total, serious adverse events	Calcitonin - Males	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00414973/event-totals